Beriberi natural history, complications and prognosis
Beriberi Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Beriberi natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Beriberi natural history, complications and prognosis |
FDA on Beriberi natural history, complications and prognosis |
CDC on Beriberi natural history, complications and prognosis |
Beriberi natural history, complications and prognosis in the news |
Blogs on Beriberi natural history, complications and prognosis |
Risk calculators and risk factors for Beriberi natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Abdelrahman Ibrahim Abushouk, MD[2]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Natural History, Complications, and Prognosis
Natural History
- In infants born to thiamine-deficient mothers, the symptoms may start as early as one month of age.
- The hepatic stores of thiamine last for only 18 days. Lack or deficient consumption leads to gradual appearance of manifestations.
- If left untreated, patients with beriberi may progress to develop heart failure, limb paresis, and delirium. However, thiamine treatment is highly effective and leads to rapid improvements.
Complications
- Common complications of Beriberi include:
- [Complication 1]
- [Complication 2]
- [Complication 3]
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
- Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.